Search

Find exactly what you’re looking for.
Search

Section
Topics
Industry
Service
Insights
Blog Series
Showing 1-11 of 11 results

On Thursday, April 14th, New Jersey’s Cannabis Regulatory Commission (“CRC” or the “Commission”) announced that adult-use (i.e., recreational) cannabis sales can begin in the Garden State at certain dispensaries on April 21, 2022. Click here to view the announcement. The announcement came days after...

New Jersey’s Cannabis Regulatory Commission (CRC) has been fully appointed and held its first meeting on April 12, 2021. Now it gets to work on setting up all aspects of New Jersey’s newly created adult-use market and overseeing New Jersey’s existing medical cannabis program. This includes, among...

Throughout 2020, Pennsylvania courts issued a series of decisions clarifying employee rights for medical cannabis patients—one related to unemployment compensation and others related to private rights of action under its medical cannabis statute, the Medical Marijuana Act (“MMA”). Under the MMA...

On December 18, 2020, just three days after the U.S. Senate adopted the Cannabidiol and Marihuana Research Expansion Act (CMREA or the Act), the U.S. Drug Enforcement Administration (DEA or the Administration) published in the Federal Register a final rule, “Controls To Enhance the Cultivation of...

On December 17, 2020, the Federal Trade Commission (FTC or the Commission) announced that it has taken action against six cannabidiol (CBD) brands for allegedly making a wide range of unsubstantiated claims about the ability of the firms’ products to treat serious health conditions (e.g., cancer...

The IRS has updated its website providing general guidance for taxpayers in the cannabis industry.The guidance does not announce any changes in law or enforcement but rather serves as a reminder of important limitations and obligations of cannabis companies:

On August 21, 2020, nearly two years after the passage of the Agriculture Improvement Act of 2018 (2018 Farm Bill), the Drug Enforcement Administration (DEA or the Agency) published an interim final rule that, according to the Agency, "merely conforms DEA's regulations to the statutory amendments to...

It has been a busy summer for the cannabis and cannabis-derived products spaces. This month alone, the U.S. Food and Drug Administration (FDA or the Agency): (1) sent to the White House Office of Management and Budget (OMB) for review a “Cannabidiol Enforcement Policy” draft guidance; (2) announced...

On October 29, 2019, the U.S. Department of Agriculture (USDA) issued a pre-publication version of its long awaited hemp production interim final rule. Public comments are due 60 days after USDA publishes the rule in the Federal Register.

This week, Pennsylvania Senators Daylin Leach (D-Montgomery/Delaware) and Sharif Street (D-Philadelphia) introduced a bill, the “Adult-Use Cannabis Act” (Senate Bill 350), that would legalize adult-use (i.e., recreational) cannabis in the Commonwealth.

On September 25, 2019, the U.S. House of Representatives overwhelmingly passed the Secure And Fair Enforcement (SAFE) Banking Act (SAFE Act) by vote of 321 to 103.

For More Information
Contact us